Your Long-Term Outlook and Staying Healthy
At a Glance
PAD is lifelong, but many people can keep it stable by taking prescribed medicines, walking regularly, controlling cholesterol, blood pressure, and diabetes, checking their feet daily, attending follow-up visits, and reporting new rest pain promptly.
Managing Peripheral Artery Disease (PAD) is more like a marathon than a sprint. While a procedure or a new medication can provide immediate relief, PAD requires a consistent, long-term strategy. Your goal is to move from “treatment” to “survivorship”—a state where you are actively managing your health to prevent the disease from progressing [1][2].
The Long-Term Outlook: By the Numbers
It is important to have a realistic understanding of how PAD typically progresses. For many people, the disease remains stable if it is managed correctly.
- Progression to Severe Disease: Population estimates suggest that for those with stable intermittent claudication, a minority (about 11%) progress to the more severe stage of Chronic Limb-Threatening Ischemia (CLTI) over time [3]. Prognosis differs markedly based on individual factors like diabetes, kidney disease, smoking, and tissue loss.
- Amputation Risk: The 5-year risk of needing a major amputation for someone with uncomplicated claudication is generally estimated to be low, around 5% [4].
- Cardiovascular Safety: The biggest long-term risk for a PAD patient is not to the leg, but to the heart and brain. People with PAD face roughly double the risk of heart-related events compared to those without the disease [3][5]. This risk remains elevated even if you don’t have leg symptoms [3]. Good treatment lowers this risk, but cannot guarantee the disease will remain stable.
Your Individualized Follow-up Plan
To keep the disease stable, you will need a customized “health maintenance” routine. While your doctor will customize this schedule, an individualized follow-up plan typically focuses on four key areas:
1. Cardiovascular Risk Factors
Regular blood work and check-ups are essential to ensure your risk factors stay in the protective range:
- Lipids: Your goal is often a 50% reduction in LDL-C (bad cholesterol), with specific targets (such as <70 mg/dL or <55 mg/dL) determined by your clinician [6].
- Blood Pressure: Controlled to an individualized target while taking care to avoid symptoms of low blood pressure [7].
- HbA1c: If you have diabetes, consistent monitoring is critical for protecting the small vessels in your feet [8].
2. Functional Monitoring
Because we often subconsciously slow down as we age, you may not notice a decline in your walking ability.
- Walking Assessments: Formal assessments, such as the 6-minute walk test, can be used at intervals to objectively measure your endurance [3][9].
- Symptom Review: Reporting any shift from “walking pain” to “rest pain” (pain while lying down) is the most important part of your follow-up [10].
3. Post-Procedure Check-ups
If you have had a stent or a bypass, your team will prescribe a schedule using Duplex Ultrasound or ABI testing (when reliable) to ensure the repair remains open (patent) [11]. The intervals vary significantly by procedure type, conduit used, and local protocols.
4. The Daily Foot Exam
As covered in previous pages, the “gold standard” for long-term safety is the daily self-inspection of your feet [12]. This never stops, as early detection of a small blister can prevent a major complication.
The Psychological Aspect of PAD
Living with a chronic, systemic disease can take a mental toll. Research shows that psychological symptoms are common among PAD patients:
- Anxiety and Depression: Estimates vary, but one study noted roughly 38% of people with PAD experience anxiety, and up to 48% may experience depressive symptoms [13].
- The Impact on Health: Depression is associated with poorer physical activity and outcomes. Patients with untreated depression may have a decline in daily walking steps and face a higher risk of hospitalizations [14][15].
- Quality of Life: Using disease-specific tools like the VascuQoL-6 questionnaire can help you and your doctor track how the disease is affecting your well-being [16]. Discuss any symptoms or urgent mental-health concerns with your clinician.
Staying Empowered
A PAD diagnosis is a call to action. By staying adherent to your medications, committing to a daily walking routine, and attending your surveillance appointments, you are taking control of your vascular health. While the disease is lifelong, many patients find that the lifestyle changes they make to manage PAD actually leave them feeling healthier and more active than they were before their diagnosis [17][18]. Your care team is your partner in this marathon—don’t hesitate to reach out to them whenever you notice a change, no matter how small.
Common questions in this guide
What is the long-term outlook for people with PAD?
Does PAD increase my risk of heart attack or stroke even if my legs feel better?
How often should my walking ability be reassessed?
What testing is needed after a PAD stent or bypass?
Why is a daily foot check important with PAD?
Can depression or anxiety affect my PAD care?
What cholesterol and blood pressure targets should I have with PAD?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my current risk factors, what is my specific, individualized target LDL cholesterol and blood pressure level for the next year?
- 2.How often should we formally reassess my walking ability to objectively track my progress?
- 3.If I have had a bypass or stent, what is my individualized schedule for ultrasound surveillance to ensure the blood is still flowing?
- 4.Are there local support groups or behavioral health resources for patients living with chronic vascular disease?
- 5.Since my risk for a heart attack remains elevated even if my legs feel better, how will we monitor my heart health over the next five years?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (18)
- 1
Cutting-edge European guidelines for managing lower extremity peripheral arterial disease - Featuring selected insights on PAD management.
Buso G, Hersant J, Keller S, et al.
VASA. Zeitschrift fur Gefasskrankheiten 2025; (54(4)):225-234 doi:10.1024/0301-1526/a001186.
PMID: 40084845 - 2
2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
, Gornik HL, Aronow HD, et al.
Journal of the American College of Cardiology 2024; (83(24)):2497-2604 doi:10.1016/j.jacc.2024.02.013.
PMID: 38752899 - 3
Lower Extremity Peripheral Artery Disease Without Chronic Limb-Threatening Ischemia: A Review.
Polonsky TS, McDermott MM
JAMA 2021; (325(21)):2188-2198 doi:10.1001/jama.2021.2126.
PMID: 34061140 - 4
[Epidemiology of lower extremity artery disease].
Aboyans V, Sevestre MA, Désormais I, et al.
Presse medicale (Paris, France : 1983) 2018; (47(1)):38-46 doi:10.1016/j.lpm.2018.01.012.
PMID: 29449058 - 5
Endovascular treatment of lower extremity peripheral arterial disease.
Klein AJ, Ross CB
Trends in cardiovascular medicine 2016; (26(6)):495-512.
PMID: 27345154 - 6
Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease.
Belch JJF, Brodmann M, Baumgartner I, et al.
VASA. Zeitschrift fur Gefasskrankheiten 2021; (50(6)):401-411 doi:10.1024/0301-1526/a000969.
PMID: 34743585 - 7
Hypertension Management in Peripheral Artery Disease: A Mini Review.
Kharawala A, Nagraj S, Pargaonkar S, et al.
Current hypertension reviews 2024; (20(1)):1-9 doi:10.2174/0115734021267004231122061712.
PMID: 38083897 - 8
Challenges and opportunities in the management of type 2 diabetes in patients with lower extremity peripheral artery disease: a tailored diagnosis and treatment review.
Mahé G, Aboyans V, Cosson E, et al.
Cardiovascular diabetology 2024; (23(1)):220 doi:10.1186/s12933-024-02325-9.
PMID: 38926722 - 9
Association of six-minute walk distance with subsequent lower extremity events in peripheral artery disease.
Nayak P, Guralnik JM, Polonsky TS, et al.
Vascular medicine (London, England) 2020; (25(4)):319-327 doi:10.1177/1358863X20901599.
PMID: 32338582 - 10
Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia.
Conte MS, Bradbury AW, Kolh P, et al.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2019; (58(1S)):S1-S109.e33 doi:10.1016/j.ejvs.2019.05.006.
PMID: 31182334 - 11
Endovascular intervention for peripheral artery disease.
Thukkani AK, Kinlay S
Circulation research 2015; (116(9)):1599-613 doi:10.1161/CIRCRESAHA.116.303503.
PMID: 25908731 - 12
Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2023 update).
Bus SA, Sacco ICN, Monteiro-Soares M, et al.
Diabetes/metabolism research and reviews 2024; (40(3)):e3651 doi:10.1002/dmrr.3651.
PMID: 37302121 - 13
Depression in patients with peripheral arterial disease: A systematic review.
Brostow DP, Petrik ML, Starosta AJ, Waldo SW
European journal of cardiovascular nursing 2017; (16(3)):181-193 doi:10.1177/1474515116687222.
PMID: 28051339 - 14
Association of Depression with Walking in People with Peripheral Artery Disease: A Post-Hoc Analysis of the BIP Trial.
Golledge J, Venn A, Leicht A, et al.
Journal of atherosclerosis and thrombosis 2025; (32(9)):1101-1108 doi:10.5551/jat.65531.
PMID: 40044157 - 15
The association of comorbid depression with mortality and amputation in veterans with peripheral artery disease.
Arya S, Lee S, Zahner GJ, et al.
Journal of vascular surgery 2018; (68(2)):536-545.e2 doi:10.1016/j.jvs.2017.10.092.
PMID: 29588133 - 16
Validation of the Vascular quality of life questionnaire - 6 for clinical use in patients with lower limb peripheral arterial disease.
Larsen ASF, Reiersen AT, Jacobsen MB, et al.
Health and quality of life outcomes 2017; (15(1)):184 doi:10.1186/s12955-017-0760-3.
PMID: 28938901 - 17
Association Between Mental Health Burden, Clinical Presentation, and Outcomes in Individuals With Symptomatic Peripheral Artery Disease: A Scientific Statement From the American Heart Association.
Smolderen KG, Samaan Z, Decker C, et al.
Circulation 2023; (148(19)):1511-1528 doi:10.1161/CIR.0000000000001178.
PMID: 37781785 - 18
Exercise Therapy for Peripheral Artery Disease.
Thangada ND, McDermott MM
Current cardiology reports 2024; (26(5)):405-412 doi:10.1007/s11886-024-02043-4.
PMID: 38722492
This page is for informational purposes only and does not constitute medical advice. Your vascular or primary care clinician should personalize your PAD risk targets, walking plan, foot care, mental-health support, and follow-up schedule.
Get notified when new evidence is published on peripheral arterial disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.